Business Wire

Lenovo Delivers Solid Revenue Growth in Second Quarter FY 2017/18

Jaa

Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its second fiscal quarter ended September 30, 2017. Revenue was US$11.8 billion, a 5 percent increase year-over-year, and an 18 percent increase over the first fiscal quarter. Quarter-to-quarter revenue gains were achieved in all three of its main businesses, namely data center, mobile, and PCs and smart devices, demonstrating that strong execution of Lenovo’s three-wave strategy is producing consistently improving results across its portfolio. In the second fiscal quarter, Lenovo’s pre-tax income grew by US$104 million, rebounding significantly from the previous quarter’s loss.

Following last quarter’s launch of the most comprehensive portfolio lineup in its history, Lenovo’s Data Center Group (DCG), supported by a revamped channel structure and recorded year-over-year revenue gains outside China most notably in Europe and North America for the second quarter in a row. With new Moto phones performing well in key markets, Lenovo’s Mobile Business Group (MBG) also saw year-over-year revenue improvements, with strong shipments momentum in West Europe, North America, and Latin America, and generated solid overall revenue growth for the third consecutive quarter.

And Lenovo’s PC/Smart Devices Group (PCSD), which was again profitable in all geographies, saw a record-high 21.3 percent market share in its Europe/Middle East and Africa region; launched Star Wars: Jedi Challenges, a new AR product partnership with Disney, and celebrated the 25th anniversary of the iconic ThinkPad at the close of the quarter.

Additionally, Lenovo today finalized a joint venture agreement with Fujitsu, wherein the two companies will combine resources - leveraging Fujitsu’s capabilities in global sales, customer support, R&D and manufacturing, together with Lenovo’s global scale and presence.

As Lenovo continues to pursue high-growth opportunities and new partnerships, particularly in key markets, this new joint venture will strengthen Lenovo’s PC leadership worldwide, and help support continued profitable growth.

“In the last quarter we continued to make progress in transforming our business by executing our 3-wave strategy. We maintained industry leading profitability in our PC business and outgrew the market year-on-year. In our Data Center business our transformation is taking effect with a strengthened sales force, new global channel structure and programs, and new product competitiveness. Our mobile business turnaround is still in progress, and in most markets we saw strong premium to market growth,” said Yang Yuanqing, Lenovo Chairman and CEO. “The combination of strong execution and building solid foundations continue to be Lenovo’s strength. The turnaround of our business in Brazil is a good example of that. We will continue to invest in building foundation and core competence for the two new growth engines, which will bring stable and sustainable returns.”

The Company’s gross profit increased 0.3 percent year-over-year to US$1.6 billion, which was a 18.2 percent improvement quarter-to-quarter. Gross margin was 13.7 percent a slight quarterly increase. Operating profit increased by US$94 million quarter-to-quarter. Basic earnings per share was 1.26 US cents or 9.85 HK cents. Lenovo’s Board of Directors declared an interim dividend of 6.0 HK cents per share.

BUSINESS GROUP OVERVIEW

Lenovo’s PC and Smart Devices (PCSD) business group recorded an impressive year-over-year revenue increase of seven percent, up 20 percent quarter-to-quarter to US$8.4 billion. The average selling price for our PCSD products was up six percent year-over-year, as Lenovo continued to focus on innovation, a higher-value product portfolio, and de-emphasize lower-value offerings.

PCSD which includes PCs, tablets and smart devices, was again profitable in all geographies, maintaining its industry-leading profitability at 4.4 percent, as customers continued to take advantage of Lenovo’s improved product mix which led to the quarter’s improved results. Lenovo’s PC shipments were 14.5 million units, flat year-over-year, compared to a slight dip for the overall market. Lenovo’s tablet shipments were up 8.9 percent year-over-year to 2.97 million units, in a market that fell 9.4 percent.

During the quarter Lenovo and Disney introduced to rave reviews Star Wars: Jedi Challenges, a new augmented reality product that allows fans to experience Star Wars in ways never before possible. Jedi Challenges features a smartphone powered Lenovo Mirage AR headset, Lightsaber controller, Tracking Beacon, and hours of Star Wars gameplay, available this holiday season. Pre-order momentum has been very encouraging. Lenovo also celebrated the 25 anniversary of its iconic ThinkPad, with over 125 million units shipped since its introduction and still going strong with models such as the ThinkPad X1 Carbon.

In our Data Center Group (DCG), which includes servers, storage, networking, software and services, we saw solid year-over-year revenue growth in both the North America, and Europe/Middle East and Africa markets. In particular, in North America we achieved a DCG revenue increase of ten percent, as investments in a revamped channel structure, a new product portfolio, sales training and new partnerships continued to drive the transformation of the data center business for the second consecutive quarter.

Lenovo also saw improvement in China with a seven percent revenue increase quarter-to-quarter. While the last few quarters in China have been challenging, the improvements that have been put in place including new leadership and an expanded sales force, are helping to turn this business around there and drive new customer wins across hyperscale, big data, and private cloud. Lenovo’s global accounts grew strongly again 18% year on year and services bookings grew over 100% year on year setting up a strong foundation for the future. Software Defined Infrastructure showed continued strong growth in the second quarter. Lenovo’s data center momentum is evidenced by recent successes in high-performance computing, with continued wins and projects from some of the world’s largest customers and universities.

Lenovo’s Mobile Business Group (MBG), which includes Moto and Lenovo-branded smartphones grew revenue slightly year-over year, and a notable 19 percent quarter-to-quarter, driven by strong momentum for Moto-branded smartphones and the third consecutive quarter of growth. Both Moto G and Moto E models saw year-over-year demand increase significantly, while Moto Z activation increased 18 percent quarter-to-quarter. The attach rate for Moto Mods improved to 37 percent, up from the previous quarter’s 30 percent.

Worldwide, Lenovo shipped 15.3 million smartphones, a 10 percent increase year-to-year and a 37 percent increase quarter-to-quarter. Included in this total increase were strong performances in Western Europe (shipments up 71 percent), Latin America (up 69 percent) and North America (up 67 percent). In Latin America, Lenovo achieved record market share of 17.7 percent, growing by 6.5 share points year-over-year.

Lenovo continued its strategy of protecting its leading position in Latin America by expanding share and improving profit there, while attacking in mature markets such as North America, where we gained 1.7 share points year-over-year, and in Western Europe. Lenovo also continued to pursue healthy growth in key emerging markets such as India, where we grew 14 percent year-over-year and 83 percent quarter-to-quarter.

About Lenovo

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$43 billion global Fortune 500 company and a leader in providing innovative consumer, commercial, and data center technology. Our portfolio of high-quality, secure products and services covers PCs (including the legendary Think and multimode Yoga brands), workstations, servers, storage, networking, software (including ThinkSystem and ThinkAgile solutions), smart TVs and a family of mobile products like smartphones (including the Motorola brand), tablets and apps. Join us on LinkedIn, follow us on Facebook or Twitter (@Lenovo) or visit us at http://www.lenovo.com/.

         

LENOVO GROUP

FINANCIAL SUMMARY

For the fiscal quarter ended September 30, 2017

(in US$ millions, except per share data)

 
 

Q2
17/18

   

Q2
16/17

   

Y/Y CHG

Revenue 11,761     11,231     5%
Gross profit 1,613     1,607     -
Gross profit margin 13.7%     14.3%     -0.6pts
Operating expenses (1,525)     (1,392)     10%
Expenses-to-revenue ratio 13.0%     12.4%     0.6pts
Operating profit 88     215     -59%
Other non-operating expenses (53)     (47)     10%
Pre-tax income 35     168     -79%
Taxation 118     (16)     N/A
Profit for the period 153     152     1%
Non-controlling interests (14)     5     N/A

Profit attributable to
equity holders

139     157     -11%

EPS (US cents)

Basic
Diluted

 

1.26
1.26

   

1.42

1.42

   

-0.16

-0.16

Contact information

Press:
Hong Kong
Angela Lee, +852 2516 4810
angelalee@lenovo.com
or
United States
Ray Gorman, +1 919 257 6325
rgorman@lenovo.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting21.10.2018 01:30Tiedote

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme